Pseudoephedrine Articles
FDA YEAR-END DRUG APPROVALS ROLL-OUT
4 January 1993
NORTH AMERICA'S OTC COUGH COLD MARKET
9 March 1992
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
